Why the study?
Does acetylsalicylic acid prevent cardiovascular diseases in the context of primary prevention?
Does acetylsalicylic acid prevent cardiovascular diseases in the context of primary prevention?
This document presents the resolution of a Russian Expert Council on the use of acetylsalicylic acid for primary prevention of cardiovascular diseases based on updated clinical guidelines.
Answers are grounded in this paper and cite their sources.
Informs individualized aspirin decisions in primary CVD prevention; extends prior recommendations with new data.
Expert Council: Drapkina O. M., Vavilova T. V., Karpov Yu. A., Kobalava Zh. D., Lomakin N. V., Martynov A. I., Roitman E. V., Sychev D. A.Scientific communities: the Russian Society for the Prevention of Non-Communicable Diseases (ROPNIZ), the Russian Scientific Medical Society of Therapists (RNMOT), the Russian Antithrombotic Forum (RAF), the National Association for Thrombosis and Hemostasis (NATH).
No takes yet. Share an insight, caveat, or question.
Драпкина et al. (2023) conducted a review in Primary prevention of cardiovascular diseases. Acetylsalicylic acid was evaluated. An Expert Council resolution provides updated guidance on the use of acetylsalicylic acid for the primary prevention of cardiovascular diseases based on new scientific data.
Synapse has enriched 10 related papers. Consider them for comparative context: